Literature DB >> 24122887

Dab2, megalin, cubilin and amnionless receptor complex might mediate intestinal endocytosis in the suckling rat.

María D Vázquez-Carretero1, Marta Palomo, Pablo García-Miranda, Inmaculada Sánchez-Aguayo, María J Peral, María L Calonge, Anunciación A Ilundain.   

Abstract

We previously proposed that Dab2 participates in the endocytosis of milk macromolecules in rat small intestine. Here we investigate the receptors that may mediate this endocytosis by studying the effects of age and diet on megalin, VLDLR, and ApoER2 expression, and that of age on the expression of cubilin and amnionless. Of megalin, VLDLR and ApoER2, only the megalin expression pattern resembles that of Dab2 previously reported. Thus the mRNA and protein levels of megalin and Dab2 are high in the intestine of the suckling rat, down-regulated by age and up-regulated by milk diet, mainly in the ileum. Neither age nor diet affect ApoER2 mRNA levels. The effect of age on VLDLR mRNA levels depends on the epithelial cell tested but they are down-regulated by milk diet. In the suckling rat, the intestinal expressions of both cubilin and amnionless are similar to that of megalin and megalin, cubilin, amnionless and Dab2 co-localize at the microvilli and in the apical endocytic apparatus. Co-localization of Dab2 with ApoER2 and VLDLR at the microvilli and in the apical endocytic apparatus is also observed. This is the first report showing intestinal co-localization of: megalin/cubilin/amnionless/Dab2, VLDLR/Dab2 and ApoER2/Dab2. We conclude that the megalin/cubilin/amnionless/Dab2 complex/es participate in intestinal processes, mainly during the lactation period and that Dab2 may act as an adaptor in intestinal processes mediated by ApoER2 and VLDLR.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  AMNIONLESS; CUBILIN; Dab2; INTESTINE; MEGALIN

Mesh:

Substances:

Year:  2014        PMID: 24122887     DOI: 10.1002/jcb.24685

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  7 in total

1.  NRF2-Independent Regulation of Intestinal Constitutive Androstane Receptor by the Pro-Oxidants Cadmium and Isothiocyanate in hUGT1 Mice.

Authors:  Miles Paszek; Robert H Tukey
Journal:  Drug Metab Dispos       Date:  2019-11-08       Impact factor: 3.922

2.  Lysosome-Rich Enterocytes Mediate Protein Absorption in the Vertebrate Gut.

Authors:  Jieun Park; Daniel S Levic; Kaelyn D Sumigray; Jennifer Bagwell; Oznur Eroglu; Carina L Block; Cagla Eroglu; Robert Barry; Colin R Lickwar; John F Rawls; Stephen A Watts; Terry Lechler; Michel Bagnat
Journal:  Dev Cell       Date:  2019-08-29       Impact factor: 12.270

3.  Prevention of neural tube defects in Lrp2 mutant mouse embryos by folic acid supplementation.

Authors:  Julia A Sabatino; Bethany A Stokes; Irene E Zohn
Journal:  Birth Defects Res       Date:  2017-01-20       Impact factor: 2.344

Review 4.  The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals.

Authors:  Björn Weström; Ester Arévalo Sureda; Kateryna Pierzynowska; Stefan G Pierzynowski; Francisco-José Pérez-Cano
Journal:  Front Immunol       Date:  2020-06-09       Impact factor: 7.561

5.  Lack of megalin expression in adult human terminal ileum suggests megalin-independent cubilin/amnionless activity during vitamin B12 absorption.

Authors:  Louise L Jensen; Rikke K Andersen; Henrik Hager; Mette Madsen
Journal:  Physiol Rep       Date:  2014-07-22

6.  Parallel mRNA, proteomics and miRNA expression analysis in cell line models of the intestine.

Authors:  Finbarr O'Sullivan; Joanne Keenan; Sinead Aherne; Fiona O'Neill; Colin Clarke; Michael Henry; Paula Meleady; Laura Breen; Niall Barron; Martin Clynes; Karina Horgan; Padraig Doolan; Richard Murphy
Journal:  World J Gastroenterol       Date:  2017-11-07       Impact factor: 5.742

Review 7.  Delivery of Orally Administered Digestible Antibodies Using Nanoparticles.

Authors:  Toshihiko Tashima
Journal:  Int J Mol Sci       Date:  2021-03-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.